Biosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth Study.
Price
D A
DA
Department of Child Health, Royal Manchester Children's Hospital, Pendlebury.
Johnston
D I
DI
Betts
P R
PR
Buckler
J M
JM
Donaldson
M D
MD
D002648:Child; D004334:Drug Administration Schedule; D005260:Female; D005602:France; D005858:Germany; D006130:Growth Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D013006:Growth Hormone / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008485:Medical Audit; D011994:Recombinant Proteins / Q000627:therapeutic use; D013548:Sweden / Q000453:epidemiology; D016896:Treatment Outcome; D014424:Turner Syndrome / Q000150:complications; D006113:United Kingdom / Q000453:epidemiology
D011994:Recombinant Proteins; D013006:Growth Hormone